SEC Filing Summary: Systemax Inc. (Form 10-K)
Business Context and Reporting Period
Company: Systemax Inc. (Note: Input metadata referenced "GLOBAL INDUSTRIAL Co," but the filing text identifies the registrant as Systemax Inc.)
Reporting Period: Fiscal year ended December 31, 2005.
Business Overview: Systemax is a direct marketer of brand name and private label products, organized into two segments: Computer Products (92% of sales) and Industrial Products (8% of sales). Operations are conducted in North America and Europe.
Filing Status: The filing was delayed due to a restatement of 2004 financial statements and the resignation of the former auditor, Deloitte & Touche LLP. Ernst & Young LLP was engaged as the new independent auditor.
Key Financial Metrics (Year Ended Dec 31, 2005)
| Metric | 2005 | 2004 (Restated) |
|---|---|---|
| Net Sales | $2,115.5 million | $1,928.1 million |
| Gross Profit | $307.3 million (14.5% margin) | $286.5 million (14.9% margin) |
| Operating Income | $34.8 million | $19.0 million |
| Net Income | $11.4 million | $10.2 million |
| EPS (Diluted) | $0.31 | $0.29 |
| Operating Cash Flow | $35.0 million | $12.8 million |
| Working Capital | $169.8 million | $148.0 million |
| Total Debt (Short + Long Term) | $34.8 million | $33.7 million |
| Cash and Equivalents | $70.9 million | $36.3 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 9.7% to $2.12 billion, driven by a 15.3% increase in North American sales and a 26% surge in e-commerce sales ($650 million).
- Profitability: Operating income rose 83.2% to $34.8 million, despite a decline in gross margin percentage (14.5% vs 14.9%) due to increased warehouse costs. Selling, general, and administrative (SG&A) expenses decreased as a percentage of sales to 12.7% from 13.5%.
- European Operations: European sales remained flat in USD terms (-0.2%) but declined in local currency. The segment reported an operating loss of $4.6 million, improved from a $12.4 million loss in 2004, following restructuring actions.
- Restructuring: The company incurred $4.2 million in restructuring charges in 2005, primarily for European workforce reductions (240 positions), compared to $7.4 million in 2004.
- Tax Provision: The effective tax rate increased significantly to 65.2% in 2005 (from 38.5% in 2004) due to a $10.2 million valuation allowance recorded against UK deferred tax assets.
Guidance, Outlook, Risks, and Unusual Items
- Internal Controls: Management identified three material weaknesses in internal controls over financial reporting as of December 31, 2005, including insufficient personnel resources at remote locations and inadequate processes for inventory estimation. Disclosure controls were deemed ineffective.
- Restatement: Financial statements for 2004 and 2003 were restated due to errors in inventory accounting at the Tiger Direct subsidiary and revenue recognition policies. This led to a change in auditors.
- Liquidity: The company increased its revolving credit facility from $70 million to $120 million in October 2005. As of year-end, $97.6 million was available.
- Legal Proceedings: Shareholder derivative lawsuits regarding the financial restatements were settled in May 2006. The company agreed to pay $300,000 in legal fees and adopt corporate governance changes, including appointing a Lead Independent Director.
- Future Risks: Risks include intense competition, inventory obsolescence, foreign currency fluctuations, and the potential impact of adopting SFAS 123R (Share-Based Payment) in 2006.
Investor Verification Checklist
- Internal Control Remediation: Verify the progress of remediation plans for the identified material weaknesses in inventory and financial reporting controls.
- UK Tax Position: Assess the likelihood of realizing the UK deferred tax assets currently subject to a full valuation allowance.
- European Turnaround: Monitor the effectiveness of European restructuring in returning the segment to profitability.
- Restatement Impact: Review the specific adjustments made to 2004 and 2003 financials to ensure no further restatements are required.
- Compliance Status: Confirm the company's ability to file future quarterly reports on time to avoid delisting risks from the NYSE.